Loading...
Torrent Pharma Stock Rises 4% Following Solid Q3 Performance; Market Optimistic on JB Merger Advantages
LIVE TV
LOCAL
ENGLISH
For You
Entertainment
National
Sports
Markets
Business & Economy
Lifestyle
World
Astrology & Religion
Technology
Education & Jobs
Auto
Politics
Viral
Opinions
Loading more articles...
Home
Local
Live TV
Torrent Pharma Shares Surge 4% on Strong Q3, JB Merger Benefits Boost Investor Confidence
C
CNBC TV18
•
16-02-2026, 09:21
Torrent Pharma Shares Surge 4% on Strong Q3, JB Merger Benefits Boost Investor Confidence
•
Torrent Pharmaceuticals shares gained 4% after reporting Q3 earnings largely in-line with Street expectations.
•
The company completed the acquisition of a controlling stake in JB Chemicals & Pharmaceuticals Ltd., with merger synergies anticipated.
•
Nuvama Institutional Equities and Citi retained 'Buy' ratings, citing strong performance and merger benefits.
•
Torrent's Q3 net profit rose 26.3% to ₹635 crore, and revenue grew 17.6% to ₹3,303 crore.
•
Management expects ₹400-450 crore in cost synergies from the JB Pharma acquisition over the next 2-3 years.
Read Full Article on Cnbc in English
✦
More like this
✦
More like this
Torrent Pharma Q3 Profit Jumps 26% to ₹635 Cr, Declares ₹29 Dividend
C
CNBC Awaaz
NGL Fine Chem: ₹1 Lakh to ₹1.52 Crore in 15 Years, A Multibagger Success Story
N
News18
Aurobindo Pharma Shares Surge Post Q3 Results, Street Awaits Management Commentary
C
CNBC TV18
Lenskart Q3 Profit Soars 28%, Revenue Jumps; Acquires New Company Abroad
M
Moneycontrol
Buzzing Stocks: KSB, Sanofi Shares Soar Up to 15% on Strong Q3 Results
C
CNBC TV18
GMM Pfaudler Swings to ₹8 Cr Loss in Q3 Despite Revenue Growth
C
CNBC TV18
